Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuta Katayama

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|May 6, 2008
Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donorNaoko Murashige, Masahiro Kami, Shin-ichiro Mori, et al.
International Journal of Hematology|April 10, 2022
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donorsRiko Tsumanuma, Eijiro Omoto, Hiroaki Kumagai, et al.
International Journal of Oncology|August 4, 2004
Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cellsYuta Katayama, Akira Sakai, Yoshiko Okikawa, et al.
Transplantation and Cellular Therapy|May 14, 2021
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationMasaaki Hotta, Atsushi Satake, Hideaki Yoshimura, et al.
Transplant Immunology|November 1, 2019
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Akiko Konishi, Yukie Tsubokura, et al.
International Journal of Oncology|November 21, 2008
Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myelomaYoshiaki Kuroda, Akira Sakai, Naohiro Tsuyama, et al.
Leukemia & Lymphoma|November 21, 2018
Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioningKaito Harada, Masamitsu Yanada, Shinichiro Machida, et al.
Transplantation and Cellular Therapy|May 15, 2021
Pretransplantation Red Blood Cell and Platelet Transfusion Burden in De Novo Myelodysplastic Syndrome Undergoing Allogeneic TransplantationTakaaki Konuma, Jun Aoki, Yukiyasu Ozawa, et al.
International Journal of Hematology|May 10, 2022
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemiaShuichi Mizuta, Tomotaka Ugai, Harumi Kato, et al.
American Journal of Hematology|June 27, 2024
An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHDYoshihiro Inamoto, Koji Kato, Toshiro Kawakita, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|May 6, 2008
Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donorNaoko Murashige, Masahiro Kami, Shin-ichiro Mori, et al.
International Journal of Hematology|April 10, 2022
The safety and efficacy of hematopoietic stem cell mobilization using biosimilar filgrastim in related donorsRiko Tsumanuma, Eijiro Omoto, Hiroaki Kumagai, et al.
International Journal of Oncology|August 4, 2004
Cyclin D1 overexpression is not a specific grouping marker, but may collaborate with CDC37 in myeloma cellsYuta Katayama, Akira Sakai, Yoshiko Okikawa, et al.
Transplantation and Cellular Therapy|May 14, 2021
Elevation of Early Plasma Biomarkers in Patients with Clinical Risk Factors Predicts Increased Nonrelapse Mortality after Allogeneic Hematopoietic Stem Cell TransplantationMasaaki Hotta, Atsushi Satake, Hideaki Yoshimura, et al.
Transplant Immunology|November 1, 2019
Effects of recombinant thrombomodulin on long-term prognosis after allogeneic hematopoietic stem cell transplantationShosaku Nomura, Akiko Konishi, Yukie Tsubokura, et al.
International Journal of Oncology|November 21, 2008
Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myelomaYoshiaki Kuroda, Akira Sakai, Naohiro Tsuyama, et al.
Leukemia & Lymphoma|November 21, 2018
Prognostic impact of melphalan dose and total body irradiation use in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation with reduced-intensity conditioningKaito Harada, Masamitsu Yanada, Shinichiro Machida, et al.
Transplantation and Cellular Therapy|May 15, 2021
Pretransplantation Red Blood Cell and Platelet Transfusion Burden in De Novo Myelodysplastic Syndrome Undergoing Allogeneic TransplantationTakaaki Konuma, Jun Aoki, Yukiyasu Ozawa, et al.
International Journal of Hematology|May 10, 2022
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemiaShuichi Mizuta, Tomotaka Ugai, Harumi Kato, et al.
American Journal of Hematology|June 27, 2024
An open-label study of belumosudil, a selective ROCK2 inhibitor, as second or subsequent line of therapy for steroid-dependent/steroid-resistant chronic GVHDYoshihiro Inamoto, Koji Kato, Toshiro Kawakita, et al.
Pageof 16